{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:44:56Z","timestamp":1771854296476,"version":"3.50.1"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,4,16]]},"DOI":"10.1001\/jama.2024.0799","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T15:01:52Z","timestamp":1711033312000},"page":"1274","source":"Crossref","is-referenced-by-count":9,"title":["Predicting Liver-Related Outcomes in Steatotic Liver Disease"],"prefix":"10.1001","volume":"331","author":[{"given":"Zobair M.","family":"Younossi","sequence":"first","affiliation":[{"name":"The Global NASH Council, Washington, DC"},{"name":"Beatty Center for Liver and Obesity Research, Inova Health System, Falls Church, Virginia"},{"name":"Center for Outcomes Research in Liver Disease, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"4","key":"jed240005r1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"10","key":"jed240005r2","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019.","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"issue":"8","key":"jed240005r3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/jamainternmed.2014.2903","article-title":"The portrait of an adult liver transplant recipient in the United States from 1987 to 2013.","volume":"174","author":"Stepanova","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"1","key":"jed240005r4","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000352","article-title":"The changing epidemiology of adult liver transplantation in the United States in 2013-2022: the dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease.","volume":"8","author":"Younossi","year":"2023","journal-title":"Hepatol Commun"},{"issue":"4","key":"jed240005r5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis.","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"13","key":"jed240005r6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010214","article-title":"Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"jed240005r7","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"jed240005r8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/hep4.1054","article-title":"Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease.","volume":"1","author":"Younossi","year":"2017","journal-title":"Hepatol Commun"},{"issue":"12","key":"jed240005r9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/apt.v57.12","article-title":"The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease.","volume":"57","author":"Younossi","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"jed240005r10","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1053\/j.gastro.2020.12.003","article-title":"The association of histologic and noninvasive tests with adverse clinical and patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis.","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"jed240005r11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","article-title":"Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.","volume":"76","author":"Boursier","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"jed240005r12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/apt.v57.3","article-title":"A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis.","volume":"57","author":"Younossi","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"jed240005r13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","article-title":"Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores.","volume":"78","author":"Sanyal","year":"2023","journal-title":"J Hepatol"},{"key":"jed240005r14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.1447","article-title":"Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease.","author":"Lin","journal-title":"JAMA"},{"issue":"4","key":"jed240005r15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from Global Burden of Disease 2009-2019.","volume":"75","author":"Golabi","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"jed240005r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.23923","article-title":"Performance of the enhanced liver fibrosis test to estimate advanced fibrosis among patients with nonalcoholic fatty liver disease.","volume":"4","author":"Younossi","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"jed240005r17","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000340","article-title":"Identification of high-risk patients with nonalcoholic fatty liver disease using noninvasive tests from primary care and endocrinology real-world practices.","volume":"12","author":"Younossi","year":"2021","journal-title":"Clin Transl Gastroenterol"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2816453\/jama_younossi_2024_ed_240005_1712256205.21897.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T15:42:39Z","timestamp":1713282159000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2816453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":17,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,4,16]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.0799","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,16]]}}}